Search results
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including...
Morningstar· 1 day agoJERSEY CITY, N.J., April 28, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's ...
Ginkgo Bioworks nominates two new board members By Investing.com
Investing.com· 4 hours agoGinkgo Bioworks (NYSE: DNA), a company engaged in cell programming and biosecurity, has announced...
Layoffs 2024: 3 Stocks That Ought to Copy Tesla's Job Cuts
InvestorPlace· 7 days agoThe rubber hit the road on April 15 as Tesla (NASDAQ:TSLA) announced it was cutting more than 10% of...
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 4 days agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 19 hours agoIn other words, CVS is one of the main sellers in a marketplace it manages. And on Friday, Cigna’s...
Policymakers should support patients over profits in Louisiana
Louisiana Illuminator via Yahoo News· 19 hours agoEvery year, more than 26,000 Louisianans are diagnosed with cancer. Our state has the sixth-highest...
Why Cigna (CI) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 15 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Civil RICO Suit Accuses Big Pharma and Benefit Managers of Insulin Price-Fixing | Connecticut Law...
Law.com· 6 days agoLLC, Evernorth Health Inc., Express Scripts Inc., Express Scripts administrators, Medco Health...
Insulin affordability impacts public health
Chicago Tribune· 5 days agoThe suit accused major drug manufacturers and pharmacy benefit managers such as Sanofi-Aventis, Novo Nordisk, CaremarkPCS Health, Express Scripts, CVS...
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
Morningstar· 6 days agoThe Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that ...